# Xinglinxing Investment Management

Xinglinxing Investment Management is a Private Equity based in Nanjing, China.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Nanjing, China
- **Region:** Asia
- **Address:** Nanjing, China
- **Assets under management:** Undisclosed
- **LinkedIn:** linkedin.com/company/xinglin-company-limited

## Regulatory record

- **Reports private funds:** No

## About

Xinglinxing Investment Management is a private equity firm based in Nanjing, China. It focuses on venture capital investments.

## Sectors

- Healthcare Services
- Digital Health

## Questions

### What is Xinglinxing's investment mandate?

Xinglinxing operates as a healthcare-specialist private equity firm, deploying across seed, start-up, expansion, late-stage, and pre-IPO rounds. A dedicated fund-of-funds sleeve complements the direct investment activity, allocating capital to external healthcare-focused managers. The firm does not invest outside the healthcare and life sciences sectors.

### Is Xinglinxing structured as a pure direct investor or a hybrid platform?

The firm runs both a direct investment arm and a fund-of-funds program, both dedicated to healthcare. This hybrid structure is unusual among China's domestic PE platforms, where most firms operate purely direct strategies. It allows Xinglinxing to evaluate external managers while maintaining proprietary sourcing capabilities.

### Where does Xinglinxing source its investment opportunities?

Xinglinxing is headquartered in Nanjing, within Jiangsu province — a dense biotech corridor that generates significant deal flow locally. The firm also evaluates opportunities across other Chinese healthcare innovation hubs, including Shanghai and Suzhou, drawing on domestic scientific networks. Its fund-of-funds relationships provide additional deal access through external manager channels.

### What stages does Xinglinxing target within healthcare investing?

Xinglinxing covers the full healthcare investment lifecycle, from early-stage seed and start-up rounds through expansion and late-stage growth, including pre-IPO placements. The fund-of-funds sleeve allows allocation to managers with complementary stage focus, broadening the firm's effective coverage without direct mandate drift.

## Related profiles

- [Xinghua Dingli Capital](https://altss.com/profile/xinghua-dingli-capital)
- [Xingmi Asset Management](https://altss.com/profile/xingmi-asset-management)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/xinglinxing-investment-management

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology